Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
17%
ALSO IN OZEM
OZEM
22
HOLDINGS
19%
ALSO IN PPH
SECTOR DRIFT (PPH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.2% | 15.3% | 15.3% |
 |
NOVO-NORDISK A/S-SPONS ADR | 7.3% | 22.0% | 7.3% |
|
PFIZER INC | 4.7% | 4.0% | 4.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.4% | 3.2% | 3.2% |
PPH Overweight Relative to OZEM
 |
NOVARTIS AG-ADR | 10.1% |
|
MERCK & CO. INC. | 9.2% |
|
ELI LILLY & CO | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
 |
SANOFI-AVENTIS-ADR | 4.3% |
|
MCKESSON CORP | 4.3% |
|
JOHNSON & JOHNSON | 4.2% |
|
ABBVIE INC | 4.1% |
|
CENCORA INC | 3.9% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -14.7% |
|
ROCHE HOLDING LTD | -4.2% |
|
ZEALAND PHARMA A/S | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
 |
ASCLETIS PHARMA, INC. | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
AMGEN INC | -3.5% |
 |
HANMI PHARM CO LTD | -3.4% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |